Q&A with Dr. Jeremy Krell of Revere Partners
Managing Partner & Co-Founder
Principal Series:
Revere Partners, founded in 2020, is a specialized healthcare venture capital firm that focuses on identifying investment opportunities in cutting-edge innovations within the oral and systemic health sectors. As the leading institutional VC fund in this space, Revere Partners has established a world class team, comprehensive ecosystem, and attractive edge to support portfolio growth. Each team member comes from a proven background in the field. The ecosystem aligns strategic corporations, individual investors and co-investors with Revere’s fund. Portfolio success includes a deep bench of capital sources, regulatory expertise, vendor relationships, channel partnerships and exit opportunities. Beyond the financial upside, investors gain access to deep reporting and insights on the asset category as well as join a thriving and engaged community.
Join us for a private Family Office Insights Webinar featuring Dr. Jeremy Krell, Founder & Managing Partner of Revere Partners, a venture capital fund focused on the $500B intersection of health and oral health technology. Dr. Krell and his team have built a diverse and uncorrelated portfolio designed to make care more affordable and accessible while advancing oral health science and technology. Prior to launching Revere Partners, Dr. Krell was a key leader at Oscar Health (IPO 2021) and quip (privately held Unicorn) with a proven track record of exits.
View recording of the FOI Luminary Series Interview here: https://youtu.be/M9tT4g8eCX0
October 14, 2025 at 2:15pm-3:15pm EST
RSVP & Confirmation Required
Accredited Investors Only Please
Family Office Insights is a voluntary, “opt-in” collaborative peer-to-peer community of single family offices, qualified investors and institutional investors. Join the community here www.familyofficeinsights.com
What inspired you to launch Revere Partners?
Revere Partners was founded to address this gap, building the first independent venture platform exclusively focused on oral-systemic health innovation. By investing in founders at this intersection, we not only generate outsized returns but also improve the way healthcare is delivered globally.
How does Revere Partners differentiate itself from other venture funds?
Our competitive advantage comes from focus and expertise. We’ve built proprietary deal flow with over 1,500 companies in our pipeline, guided by a clinical advisory board that ensures technical and medical diligence beyond what generalist funds can offer. This specialization allows us to secure early access to transformative companies and structure investments in ways that maximize both patient impact and investor returns.
What excites you most about the opportunity ahead with Fund III?
Fund III is our first $100M institutional-grade vehicle, and it represents the scaling of everything we’ve built over the past 5 years. With 70% allocated to new investments and 30% to follow-ons, we’re positioned to back category leaders in a market that’s only just beginning to be recognized as central to healthcare innovation. The convergence of oral and systemic health is one of the biggest untapped opportunities in venture capital and Revere is at the forefront of it.
Dr. Jeremy Krell of Revere Partners
Dr. Jeremy Krell is a general dentist, startup operator, and Investor. Managing Partner of Revere Partners, he built Barchester Bay Group, overseeing 40+ ventures, and contributed to the success of Oscar Health, which had an IPO, and quip (VC-backed unicorn). Jeremy also serves in several Board and leadership capacities, including Chairman of HPU WSDM. He is actively shaping the future of dentistry.
Contact Dr. Jeremy: jeremy@reverepartnersvc.com